Cupino, Melanie .

HRN: 22-85-96  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2023
CEFUROXIME 1.5GM (VIAL)
12/16/2023
12/22/2023
IV
1.5 G
Q8
CAP MR
Waiting Final Action 
12/16/2023
AZITHROMYCIN 500MG TABLET (TAB)
12/16/2023
12/20/2023
ORAL
500mg
OD
CAP MR
Waiting Final Action 
12/18/2023
CEFUROXIME 500MG (TAB)
12/18/2023
12/25/2023
PO
500mg Tab
BID
Ba In Ae; CAP-MR
Waiting Final Action 
12/20/2023
CEFTRIAXONE 1G (VIAL)
12/20/2023
12/20/2023
IV
1 Gram
Q12
CAP-MR ; BAIAE; G3P1 (1011) 25 6/7 Weeks AOG
Waiting Final Action 
12/25/2023
CEFUROXIME 500MG (TAB)
12/25/2023
01/01/2024
PO
500 Mg Tab
BID
CAP-MR; BA In AE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: